
This pharma stock made investors nearly 200% wealthier in a year, Goldman Sachs suggests buying more
Goldman Sachs says it continues to prefer Syngene and Neuland over Divi’s, on which it has a neutral call, and Gland Pharma and Laurus Labs,…

Goldman Sachs says it continues to prefer Syngene and Neuland over Divi’s, on which it has a neutral call, and Gland Pharma and Laurus Labs,…

Indus Towers Share Price | The agreement involves procuring 130 MW of renewable energy from a solar photovoltaic (PV) plant under a captive model, Indus…

Retail investors can apply for a minimum lot of 53 shares, requiring a minimum investment of ₹14,835 per application.

On the earnings front, although the quarters recently have been disappointing, but Morgan Stanley says that the earning cycle is midway, and the valuations, too,…

Shares of Vodafone Idea are down over 50% from their post-FPO peak of ₹19 and also trading below their FPO price of ₹11.

The Managing Director and CEO at Motilal Oswal Financial identified capital markets, financials, and capex as the top three investment themes for the year 2025.

On the charts, shares of Reliance Industries are heading towards oversold levels. The Relative Strength Index (RSI) on the charts is now at 35. An…

The latest grey market premium (GMP) for the Vishal Mega Mart IPO was ₹16 as of 11:40 AM on Friday. According to reports, the company’s…

With a gain of over 2% this week, gold is benefiting from renewed buying interest, particularly from top consumer China, which resumed its gold purchases.

Over the past seven years the Nifty 50 trend remained largely flattish on Friday, the 13th, except in 2020 and 2021 when the blue chip…